Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany
Alexander Kuhlmann, J.-Matthias Graf von der Schulenburg
| Year of publication: |
April 2017
|
|---|---|
| Authors: | Kuhlmann, Alexander ; Schulenburg, Johann-Matthias von der |
| Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 18.2017, 3, p. 273-292
|
| Subject: | Pneumococcal conjugate vaccine | Cost-effectiveness | Herd protection | Vaccination | Economic evaluation | Costs | Impfung | Kosten-Wirksamkeits-Analyse | Cost-effectiveness analysis | Arzneimittel | Pharmaceuticals | Deutschland | Germany | Gesundheitspolitik | Health policy | Gesundheitsökonomik | Health economics | Kosten-Nutzen-Analyse | Cost-benefit analysis | Gesundheitskosten | Health care costs | Theorie | Theory | Infektionskrankheit | Infectious disease | Gesundheitsvorsorge | Preventive care | Pharmaindustrie | Pharmaceutical industry |
Kommentar in:
Gandjour, Afschin *1968-*. Comment on "Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany", 2018
Persistent link: https://www.econbiz.de/10011868215